Opportunity
SAM #36C24126Q0530
Sole Source Replacement and Upgrade of ScriptPro Pharmacy Automation Equipment at VA Boston Healthcare System
Buyer
Department of Veterans Affairs
Posted
July 13, 2026
Respond By
July 20, 2026
Identifier
36C24126Q0530
NAICS
423450, 339112
This opportunity is a sole-source procurement by the Department of Veterans Affairs for pharmacy automation equipment upgrades at VA Boston Healthcare System campuses. - Agency: Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 1 New England - Vendor: ScriptPro USA, Inc. (sole-source, OEM-authorized) - Locations: VA Boston Healthcare System campuses (West Roxbury, Jamaica Plain, Brockton) - Products: - Replacement of end-of-life ScriptPro robotic dispensing equipment - GEN9 proprietary upgrade - Workflow Management System (WMS 1.0 and 2.0) - Datapoint components - Firmware - Services: - Configuration services (server/firmware transitions, Datapoint/terminal emulation, VistA integration) - Requirements: - All products/services must be compatible with VistA-integrated pharmacy workflows - Only ScriptPro is authorized to provide these upgrades and equipment - Pricing based on ScriptPro's VA Federal Supply Schedule (FSS Contract 36F79719D0135) - No other manufacturers or distributors are eligible or capable of performing these OEM upgrades - Commercial opportunity is limited to ScriptPro due to proprietary and technical requirements
Description
The Department of Veterans Affairs, Veterans Health Administration (VHA), Network Contracting Office (NCO) 1 New England, intends to award a firm-fixed-price sole-source order to ScriptPro USA, Inc. for pharmacy automation equipment and OEM-exclusive upgrades at the VA Boston Healthcare System (VABHS) campuses: West Roxbury, Jamaica Plain, and Brockton. The action replaces end-of-life ScriptPro robotic dispensing equipment and implements proprietary upgrades (including GEN9 and Workflow Management System WMS 1.0 2.0), Datapoint components, firmware, and configuration services required for safe, accurate, and efficient VistA-integrated pharmacy operations.
Authority: FAR 8.405-6(a)(1)(i) (items peculiar to one manufacturer), FAR 8.405-6(b) (limited-sources justification), MAS ordering authorities at 41 U.S.C. 152(3) and 40 U.S.C. 501, and GSAM/R 538.7104-3(b) as implemented for MAS sole-source justifications (RFO 8.4).
Rationale: Market research confirms ScriptPro retains exclusive proprietary rights to its system architecture, robotic mechanisms, software/firmware, configuration utilities, and the OEM-only installation/upgrade pathways required to maintain warranty and functionality. No SDVOSB/VOSB or other manufacturer is authorized or capable of performing OEM upgrades or providing compatible equipment; authorized distributors cannot conduct OEM-exclusive services. Replacement with ScriptPro is necessary to mitigate patient-safety risks and operational disruption. Pricing aligns to ScriptPro s VA Federal Supply Schedule price list under FSS Contract 36F79719D0135.
Intended Source: ScriptPro USA, Inc., 5828 Reeds Road, Shawnee Mission, KS 66202; Phone (800) 606-7628; Contract FSS 36F79719D0135.
NAICS/PSC: NAICS 339112; PSC 6515.
Place of Performance: VA Boston Healthcare System West Roxbury, Jamaica Plain, and Brockton campuses.
This notice is NOT a request for quotations. Nonetheless, parties that believe they can meet all requirements must submit a capability statement demonstrating (1) OEM authorization from ScriptPro for hardware, software, and services; (2) ability to perform proprietary upgrades/configurations (GEN9, WMS 2.0, server and firmware transitions, Datapoint/terminal emulation); and (3) technical compatibility with VistA-integrated pharmacy workflows. Capability statements must be received by the response due date identified on this posting.
Point of Contact: Janice L. Jones, Contract Specialist, NCO 1; Email: Janice.Jones@va.gov ; Phone: (860) 666-6951 x36613.
Disclaimer: A solicitation will not be issued. The Government reserves the right to verify all documentation and is not obligated to award based on responses. A Limited-Sources Justification supporting this sole-source action will be posted after award in accordance with FAR 8.405-6 and FAR 5.301.